EF
CVS icon

Empirical Finance’s CVS Health CVS Stock Holding History

Empirical Finance’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.75M Sell
52,254
-78
-0.1% -$6.01K 0.18% 117
2025
Q4 		$4.15M Sell
52,332
-1,906
-4% -$150K 0.2% 100
2025
Q3 		$4.09M Buy
54,238
+509
+0.9% +$34.9K 0.19% 108
2025
Q2 		$3.71M Buy
53,729
+295
+0.6% +$19.3K 0.19% 104
2025
Q1 		$3.62M Buy
53,434
+846
+2% +$50.6K 0.22% 94
2024
Q4 		$2.36M Buy
52,588
+7,959
+18% +$447K 0.14% 135
2024
Q3 		$2.81M Buy
44,629
+939
+2% +$54.8K 0.16% 116
2024
Q2 		$2.58M Sell
43,690
-3,045
-7% -$190K 0.16% 119
2024
Q1 		$3.73M Buy
46,735
+1,535
+3% +$117K 0.23% 96
2023
Q4 		$3.57M Buy
45,200
+149
+0.3% +$10.6K 0.25% 88
2023
Q3 		$3.15M Buy
45,051
+4,304
+11% +$305K 0.23% 95
2023
Q2 		$2.82M Buy
40,747
+4,196
+11% +$299K 0.22% 98
2023
Q1 		$2.72M Buy
36,551
+1,985
+6% +$166K 0.25% 86
2022
Q4 		$3.22M Buy
34,566
+2,933
+9% +$283K 0.33% 66
2022
Q3 		$3.02M Buy
31,633
+5,189
+20% +$514K 0.36% 57
2022
Q2 		$2.45M Sell
26,444
-4,994
-16% -$487K 0.31% 65
2022
Q1 		$3.18M Buy
31,438
+2,743
+10% +$288K 0.36% 56
2021
Q4 		$2.96M Buy
28,695
+559
+2% +$51.7K 0.35% 58
2021
Q3 		$2.39M Sell
28,136
-8,916
-24% -$747K 0.36% 50
2021
Q2 		$3.09M Buy
37,052
+6,424
+21% +$526K 0.5% 34
2021
Q1 		$2.09M Hold
30,628
– – 0.37% 68
2020
Q4 		$2.09M Buy
30,628
+2,347
+8% +$153K 0.37% 68
2020
Q3 		$1.65M Buy
28,281
+19,994
+241% +$1.24M 0.35% 75
2020
Q2 		$538K Buy
8,287
+1,069
+15% +$67.3K 0.14% 141
2020
Q1 		$428K Buy
7,218
+2,708
+60% +$181K 0.13% 135
2019
Q4 		$335K Buy
+4,510
New +$317K 0.08% 164
2017
Q4 		– Sell
-16,337
Closed -$1.33M – 114
2017
Q3 		$1.33M Buy
+16,337
New +$1.29M 0.46% 54
2017
Q1 		– Sell
-523
Closed -$42K – 201
2016
Q4 		$42K Buy
+523
New +$42.3K 0.03% 117

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Empirical Finance's CVS Position: Q1 2026 in Review

Empirical Finance reduced its CVS Health (CVS) stake by 0.15% in Q1 2026, selling an estimated $6.01K and leaving 52,254 shares worth $3.75M. The position accounts for 0.18% of the portfolio, ranked #117.

Empirical Finance first reported a position in CVS in Q4 2016 and has held it in 28 quarters since. The position peaked at $4.15M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Empirical Finance held 52,254 shares of CVS Health worth $3.75M as of Q1 2026.
  • Empirical Finance sold 78 CVS Health shares in Q1 2026, an estimated $6.01K.
  • CVS Health made up 0.18% of Empirical Finance's portfolio in Q1 2026, its #117 holding.
  • Empirical Finance first reported a position in CVS Health in Q4 2016 and has held it in 28 quarters since.
  • Empirical Finance's CVS Health position peaked at $4.15M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Empirical Finance's 13F filing for Q1 2026, filed 14 May 2026.